Found 14 matching trials
A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer
PHASE2This is a multicenter phase II clinical study to explore the efficacy, safe...
Location
Peking University Cancer Hospital
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
PHASE3The treatment efficacy for stage IVb esophageal cancer has been improved th...
Location
Cancer hospital, CAMS
Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer
PHASE2Based on various external factors and differences in the basic characterist...
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
PHASE2This multicenter, prospective clinical trial is designed to enroll PD-L1 ex...
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
PHASE2This prospective, phase II, multicenter, randomized controlled study aims t...
Location
The First Affiliated Hospital of Xiamen University
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
PHASE2It is a prospective, open-label, randomized, controlled phase II/III clinic...
Location
Anhui Provincial Cancer Hospital
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC
PHASE3This study is a randomized, double-blind, placebo-controlled, multi-center ...
Location
Beijing Cancer Hospital
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study
N/AEsophageal squamous cell carcinoma (ESCC) is highly prevalent in China, wit...
Location
Multiple Locations
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
PHASE2This study aims to evaluate the efficacy and safety of neoadjuvant camreliz...
Location
Shandong Cancer Hospital and Institute
Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial
PHASE3This study aims to evaluate the efficacy and safety of the TPC regimen (nab...